Pure red cell aplasia (PRCA) occurred in the fourth month after an ABO-compatible nonmyeloablative allograft coincident with the cessation of immunosuppression and the onset of limited chronic GVHD. No secondary causes could be identified. Erythropoiesis was restored promptly and durably with the resumption of immunosuppression. A clonal T cell receptor c rearrangement was detected in peripheral blood lymphocytes prior to the onset of PRCA. PRCA should be added to the list of immunohaematological complications of GVHD. Bone Marrow Transplantation (2003) 32, 1099-1101. doi:10.1038/sj.bmt.1704271 Keywords: pure red cell aplasia; GVHD Pure red cell aplasia (PRCA) is most commonly an idiopathic disorder, although secondary causes such as lymphoproliferative and myelodysplastic disorders, parvovirus infection and thymoma are well recognised.
Pure red cell aplasia (PRCA) is most commonly an idiopathic disorder, although secondary causes such as lymphoproliferative and myelodysplastic disorders, parvovirus infection and thymoma are well recognised. 1 Post transplant, PRCA is usually a complication of major ABO incompatibility and may have an increased incidence after nonmyeloablative compared with myeloablative conditioning regimens. 2 While autoimmune haematological disorders including haemolytic anaemia and immune neutropenia, thrombocytopenia and pancytopenia due to peripheral destruction are well recognised post allograft, 3 often in the context of chronic graft versus host disease (GVHD), 4 to our knowledge PRCA as an immune complication in the absence of ABO incompatibility has not been reported. This case documents PRCA after an ABO-compatible nonmyeloablative allograft in the absence of any secondary causes. The onset was coincident with the early onset of chronic GVHD and it resolved promptly after the recommencement of immunosuppression.
Case report
A 48-year-old man underwent a peripheral blood progenitor cell, ABO-matched sibling allograft in May 2002 for transformed low-grade non-Hodgkin's lymphoma relapsing after an autograft 11 months previously. A reducedintensity conditioning regimen (fludarabine 25 mg/m 2 day 6 to day 2, cyclophosphamide 1 g/m 2 day 3 to day 2) was used with cyclosporin A 3 mg/kg i.v. and short course methotrexate as GVHD prophylaxis. White cell recovery occurred early in the second week post transplant (neutrophils 40.5 Â 10 9 /l by day 10). Mild early cutaneous acute GVHD was observed requiring low-dose steroid therapy. Both cyclosporin A and prednisolone were tapered from day 60 and stopped by day 100. Table 1 details the haemoglobin (Hb) levels, marrow findings, chimerism results, immunosuppressive medication and GVHD status at various time points post transplant. Hb levels were stable around 120 g/l without transfusion by day 95, but fell thereafter by approximately 1 g/week to a nadir of 78 g/l by day 120. There was no history of blood loss. Red cell aplasia, confirmed by glycophorin immunohistochemistry, was demonstrated on a day 100 marrow aspirate ( Figure 1a ). No B cell lymphoma was demonstrated by morphology or flow cytometry. The majority of marrow lymphocytes were suppressor T cells with a CD4:CD8 ratio of 0.5. An excess of large granular lymphocytes was not seen in the peripheral blood film. Parvovirus IgM by serology and parvovirus B29 DNA by PCR were not detected. No red cell autoantibodies were demonstrated using a low-ionic strength saline solution. Direct antiglobulin testing for IgG and complement was negative. The serum erythropoietin level was 213 IU/l (normal 4-26 IU/l). Vitamin B12, folate and ferritin levels were normal or elevated. The following tests were negative: ANA and other autoantibodies (smooth muscle, mitochondrial), hepatitis B and C serology, herpes virus multiplex PCR and indirect Coomb's test. Serial CT scans pre and post transplant did not show evidence of thymoma. A CT scan at day 100 demonstrated minor residual thickening in the left paraaortic region, which had diminished compared with the pretransplant scan. PET scans at days 119 and 240 were negative. A T cell receptor (TCR) g rearrangement was detected by polymerase chain reaction in CD3 selected peripheral blood lymphocytes from early post transplant and persisted until the onset of PRCA (Table 1) .
The onset of red cell aplasia correlated with the development of clinical features of limited chronic GVHD: moderately severe oral mucosal changes and modestly abnormal liver function tests. Cyclosporin A was resumed together with oral prednisolone and ursodeoxycholic acid.
Two units of red cells were transfused on day 118. By day 138, the Hb had increased to 121 g/l with a modest reticulocytosis of 3%; this Hb has been maintained thereafter. The patient remains well with ongoing limited chronic GVHD, a normal Hb and normal marrow erythropoiesis (Figure 1b ) at 8 months post transplant. A TCR g rearrangement was detectable in a peripheral blood sample at day 160, but was no longer detectable at 8 months.
Discussion
None of the well-recognised secondary causes of PRCA could be demonstrated in this case. Specifically, the donor and recipient were ABO-compatible, the underlying lymphoma was in remission and there was no serological evidence of a systemic autoimmune disorder. Parvovirusassociated PRCA in chronic GVHD has been described, 5 but there was no serologic or molecular evidence of infection and the morphological features were not typical.
The raised erythropoietin level argues against the presence of autoantibodies to this hormone. 4, 6 The occurrence of PRCA in the context of withdrawal of immunosuppression and the emergence of chronic GVHD, together with the rapid and durable response to the resumption of immunosuppression, is suggestive of an immune process and consistent with the concept of chronic GVHD as an autoimmune disorder. 7 Primary PRCA outside the context of marrow transplantation has been attributed to humoral dysfunction producing autoantibodies against erythroid cells, or T cell-mediated inhibition of erythropoiesis. 8 Clonal TCR rearrangements have been reported in idiopathic PRCA 9 and were detected in the peripheral blood in our patient prior to the onset of PRCA and 8 weeks thereafter, but subsequently resolved. While oligoclonal expression of T cells after allografting is well recognised, with persistence particularly of CD8 þ T cell clones, 10 many T cells post transplant have abnormal phenotypes. 11 While humorally mediated PRCA cannot be excluded, it is conceivable that in our patient a clone of T cells was generated with specific cytotoxic activity against erythroid precursors. Pure red cell aplasia with the onset of GVHD
In conclusion, we suggest that PRCA should be added to the list of immunohaematological associations of chronic GVHD.
